Area of research
Cancer Research · Biotechnology
Research interest
Research focused on ErbB and Cancer research, with related work in Chimeric antigen receptor, Alendronic acid, Cytokine. Notable publications include 'Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?', 'Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells', and 'Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells'.
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid
Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?
Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells